Mass tort marketing at $300-500 CPL is a math problem. The question is whether the leads you're buying have been qualified against the criteria that actually determine case viability: exposure window, diagnosis, jurisdiction, and MDL certification status.
LeadingResponse is one of the larger mass tort lead aggregators, running TV, direct mail, and digital campaigns to generate plaintiff inquiries across active torts. Their model is volume-focused and broad: generate awareness at scale across multiple channels, aggregate the responses, and sell them to subscribing tort firms.
Last10Legal approaches mass tort intake differently. The cohort engine matches leads against exposure-window criteria, jurisdiction requirements, and MDL certification status before they route to a subscribing firm. Lower raw volume, higher qualification rate.
This comparison is for mass tort firm partners and marketing directors evaluating where the CPL spend produces the best effective cost per retained case.
For context on how mass tort lead routing compares to PI lead gen, see the mass tort leads guide.
What LeadingResponse Actually Does
LeadingResponse runs multi-channel mass tort plaintiff acquisition campaigns: TV commercials (especially cable and satellite in older demographic markets), direct mail, digital display, and search. They operate across many of the major active torts and have the infrastructure to generate high lead volumes quickly.
Their model is designed for tort rollouts where a firm needs to build a case inventory fast. A mass tort with a 2-3 year statute of limitations window and a late-discovery dynamic benefits from high-volume plaintiff outreach. LeadingResponse's broadcast-and-capture approach fills that need.
What they do well:
- ·Scale. If you need 1,000 leads on a specific tort in 90 days, LeadingResponse has the channel infrastructure to deliver volume.
- ·Cross-tort diversification. They cover multiple torts simultaneously. Firms managing multiple MDLs can buy across several torts from one vendor relationship.
- ·Established TV/direct mail channels that reach older demographics (often the relevant plaintiff cohort for certain torts like NEC baby formula or hair relaxer).
What to understand about their model:
- ·Lead qualification happens post-intake rather than pre-intake. Leads are generated via broad awareness campaigns, and the qualification layer comes from your intake team's screening rather than from the platform's routing logic.
- ·Volume doesn't equal cohort-clean leads. A person who responds to a TV ad about hair relaxer lawsuits still needs to be screened for frequency of use, specific products, uterine cancer diagnosis, and diagnosis timeline before the lead has case value.
- ·Multi-firm distribution is common. As with most mass-tort aggregators, the same lead may reach multiple subscribing firms depending on the contract structure.
When LeadingResponse Is the Right Fit
LeadingResponse works for specific firm profiles and situations:
High-volume tort campaigns with large intake capacity. If your firm has a dedicated mass tort intake team and a structured screening workflow, LeadingResponse's volume model feeds that process. Firms that can screen 500 leads per month and convert 5-8% to retained cases are the core LeadingResponse customer.
Early-stage tort rollouts where volume matters more than precision. For a new MDL in the first 6-12 months, building case inventory quickly sometimes justifies lower qualification rates. High volume at lower individual case precision can still be the right strategy depending on the settlement timeline.
Firms with TV/direct mail creative already developed. LeadingResponse's TV placement works best when firms also have their own brand presence in the channel. Firms with existing TV creative can layer LeadingResponse's distribution on top of their own campaigns.
Torts where the plaintiff pool is large and awareness is genuinely low. Some torts have millions of potentially eligible plaintiffs who don't know they may have a claim. Mass awareness campaigns make strategic sense in those scenarios.
If your firm is in growth mode on a large tort with indefinite recruitment needs, LeadingResponse's scale advantage is real.
When Last10Legal Is the Right Fit
Last10Legal's mass tort model is cohort-focused rather than volume-focused:
Firms that want exposure-window pre-qualification. For torts like Roundup (NHL + glyphosate exposure), Camp Lejeune (contaminated water 1953-1987), or hair relaxer (frequent use + uterine cancer diagnosis), exposure-window matching filters out respondents who don't meet basic eligibility criteria before the lead routes to your firm. Firms that have been burned by high-volume campaigns with poor qualification rates find this structure significantly reduces intake screening costs.
MDL-certified jurisdiction routing. Leads routing to tort firms operating in specific federal districts are checked against jurisdiction requirements before routing. A firm handling Camp Lejeune CLJA claims in E.D.N.C. only receives leads that pass the basic CLJA eligibility screen.
Smaller firms with limited intake capacity. Last10Legal's lower volume, higher-quality model fits boutique tort firms that can handle 20-50 qualified leads per month but don't have the intake infrastructure for 300 raw leads requiring deep screening.
Firms optimizing effective cost per retained case. The relevant comparison is not CPL but cost per retained case. Cohort-clean leads with higher upfront CPL but 15-25% conversion rates often outperform high-volume unqualified leads with 2-4% conversion rates on this metric.
For more on tort cohort matching and MDL certification considerations, see the mass tort leads guide.
LeadingResponse vs Last10Legal: Side-by-Side Comparison
The clearest way to choose: if your intake bottleneck is lead volume, LeadingResponse addresses that bottleneck. If your intake bottleneck is lead quality - too many respondents failing screening, too much intake staff time on unqualified calls - Last10Legal addresses that bottleneck.
What Cohort-Clean Routing Actually Means
The phrase "cohort-clean leads" gets used a lot in mass tort marketing without always being well-defined. Here's what it means in practice.
A cohort-clean lead for a mass tort has been checked against the core eligibility criteria before it reaches your intake team:
Exposure window: The plaintiff was actually exposed to the product or substance during the relevant period. For Roundup, that means confirmed glyphosate herbicide exposure, not just a general interest in the lawsuit. For Camp Lejeune, that means confirmed residence or service at the base between 1953 and 1987.
Qualifying diagnosis: For torts with specific medical requirements (NHL for Roundup, uterine cancer for hair relaxer, TCE/PCE-linked conditions for Camp Lejeune), the lead has disclosed a qualifying diagnosis rather than just a general health concern.
Jurisdiction fit: The plaintiff is in a state and situation that fits the MDL's certified jurisdiction. For federal MDLs, this matters for which district's rules apply.
Statute of limitations check: The claim isn't obviously time-barred based on diagnosis date and state SOL rules (varies by state).
What this means for your intake team: cohort-clean leads arrive having already passed the first-tier qualification filter. Your intake team's first conversation starts from a much higher baseline than a raw TV respondent who heard a commercial and called a number.
The tradeoff is volume: not every person who responded to a hair relaxer awareness campaign will have used qualifying products with qualifying frequency and have a qualifying diagnosis. Cohort filtering reduces the lead pool to those who plausibly meet threshold criteria.
Compliance in Mass Tort Lead Gen
Mass tort lead gen has compliance requirements that go beyond standard PI advertising rules.
TCPA consent at intake. Any lead gen that involves SMS or phone contact requires explicit TCPA consent on the same page as the form. TV and direct mail campaigns that route respondents to a phone line or landing page must obtain this consent. Firms buying mass tort leads should verify that the lead source has captured TCPA-compliant consent before contacting the plaintiff.
NY attorney advertising label. New York-targeted mass tort placements must include the "Attorney Advertising" disclosure. Firms handling MDL claims with NY plaintiff cohorts should verify that any lead gen platform they use applies this requirement to NY-targeted content.
MDL class action advertising disclosures. Some state bars have specific rules about advertising related to pending class actions or MDLs. The specifics vary by state bar.
Fee arrangement transparency. Mass tort cases typically involve contingency arrangements. Some states have specific disclosure requirements for contingency fee advertising in consumer-facing content.
LeadingResponse handles some of these compliance elements at the campaign level; firm-level compliance for specific bar rules remains with the subscribing attorney.
Last10Legal builds compliance requirements into the intake routing layer: TCPA consent verification, NY advertising label enforcement on NY-targeted content, and jurisdiction-level checks before leads route.
If your mass tort practice spans multiple states with varying advertising rules, verify how any lead gen platform you use handles state-level compliance before buying leads. See the legal lead gen compliance guide for a state-by-state overview.
Three Questions to Ask Any Mass Tort Lead Provider
Before committing to any mass tort lead purchasing relationship:
1. What qualification criteria have been applied before the lead reaches me? Get specifics. "Pre-qualified" is a marketing word. Ask for the exact criteria checked before a lead routes to your firm: exposure window verification method, diagnosis disclosure requirement, jurisdiction check process. If the answer is "our intake team handles qualification," you're buying unqualified leads regardless of what they call them.
2. How is TCPA consent documented, and can you provide consent records for any lead? Mass tort plaintiff outreach involves phone and SMS contact. TCPA violations carry $500-$1,500 per unsolicited contact. Any mass tort lead provider should be able to provide documented consent records for any lead they sell you. If they can't or won't, that's a material compliance gap.
3. What is your effective conversion rate from lead to retained case, by tort? Ask for this data segmented by specific tort, not aggregate. A platform might have a 12% average conversion rate but a 3% rate on the specific tort you're focused on. Aggregate metrics obscure the relevant comparison.
These questions apply to LeadingResponse, Last10Legal, and every other mass tort lead source. The answers tell you whether you're buying a managed plaintiff acquisition pipeline or a list of people who saw a TV commercial.
To explore Last10Legal's mass tort routing for your practice, the starting point is partner onboarding.